Related Experiment Video
Updated: Aug 19, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
[Role of matrix metalloproteinases in the pathogenesis of multiple sclerosis]
Jacek Kurzepa1, Halina Bartosik-Psujek, Danuta Suchozebrska-Jesionek
1Katedra i Zakład Biochemii, Katedra i Klinika Neurologii, Akademia Medyczna im. prof. Feliksa Skubiszewskiego w Lublinie, ul. Jaczewskiego 8, 20-954 Lublin, Poland.
Abstract:
Multiple sclerosis (MS) is an autoimmune disease whose features include a massive lymphocyte recruitment into the central nervous system and segmental demyelinization of the white matter. One of the MS development factors is an increase of matrix metalloproteinases (MMPs) activity with a coincidental decrease of tissue inhibitors of MMPs (TIMPs) activity. Investigations of serum, cerebrospinal fluid and brain tissue of patients showed an increase of MMP-1, -2, -3, -7, -9 and MMP-12 activity. MMPs disrupt the blood-brain barrier (BBB), increase lymphocyte migration into the central nervous system and are involved in degradation of myelin proteins. MMPs induce the appearance of an active form of tumor necrosis factor alpha, a strong proinflammatory cytokine. The drugs used in MS treatment decrease MMPs expression. Multiple actions of MMPs prove their involvement in the pathogenesis and treatment of MS.
Insights
Matrix metalloproteinases (MMPs) are implicated in multiple sclerosis (MS) pathogenesis by disrupting the blood-brain barrier and myelin. Treatments for MS aim to reduce MMPs expression, highlighting their role in disease progression and management.
Area of Science:
- Neuroimmunology
- Biochemistry
Context:
- Multiple sclerosis (MS) is an autoimmune disorder characterized by central nervous system inflammation and demyelination.
- Key pathological features include lymphocyte infiltration and myelin sheath degradation.
- Altered activity of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs) is observed in MS patients.
Purpose:
- To investigate the role of matrix metalloproteinases (MMPs) in the pathogenesis of multiple sclerosis (MS).
- To explore the correlation between MMPs activity and disease progression in MS.
- To understand the impact of MMPs on the blood-brain barrier and myelin integrity.
Summary:
- Elevated activity of MMP-1, -2, -3, -7, -9, and -12 was detected in serum, cerebrospinal fluid, and brain tissue of MS patients.
- MMPs contribute to MS by breaching the blood-brain barrier, facilitating lymphocyte entry into the CNS, and degrading myelin proteins.
- MMPs also promote the pro-inflammatory cytokine tumor necrosis factor alpha, exacerbating neuroinflammation.
Impact:
- MMPs are critical players in MS pathogenesis, influencing neuroinflammation and tissue damage.
- Current MS therapeutic strategies focus on downregulating MMPs expression.
- Understanding MMPs' multifaceted roles offers potential targets for novel MS treatments.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Multiple Sclerosis l: Introduction
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Mesenchymal Stem Cells
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
